Change in the genotypes of <i>ATM</i>, <i>ERCC1</i>, and <i>XRCC1</i>. by Hao Deng (409186)

Subjects:

Proportion of L3 recovered from forages. by Katy A. Martin (9216905)

Top 10 significant functional annotations of up-regulated DEGs. by Meitner Cadena (22216261)

“…Functional annotations are ordered by decreasing significance, with color indicating significance according to the legend’s color scale, the ratio of genes on the horizontal axis, and DEG count represented by circle size.…”

Distribution of total <i>T. colubriformis</i> recovered after 48 hours, stratified by height zone. by Katy A. Martin (9216905)

Top 10 significant functional annotations of down-regulated DEGs. by Meitner Cadena (22216261)

“…Functional annotations are ordered by decreasing significance, with color indicating significance level based on the legend’s color scale, the ratio of genes on the horizontal axis, and DEG count represented by circle size.…”

RBM-26 binds to the <i>mals-1</i> mRNA and negatively regulates its expression. by Tamjid A. Chowdhury (14149846)

Loss of MALS-1 function suppresses the mitochondrial and axon degeneration phenotypes that are caused by loss of RBM-26 function. by Tamjid A. Chowdhury (14149846)

“…For panel B, error bars represent the standard error of the mean (<i>n</i> = 25), and statistical significance was analyzed by one-way ANOVA with a Tukey post hoc test (*<i>p</i> < 0.05 and **<i>p</i> < 0.01). …”

Overexpression of MALS-1 reduces mitochondria in the PLM axon and causes axon degeneration and axon overlap defects. by Tamjid A. Chowdhury (14149846)

“…<p>(A–C) Overexpressed MALS-1::Scarlet protein colocalizes with mitochondria. …”

Loss of RBM-26 causes mitochondria dysfunction in PLM. by Tamjid A. Chowdhury (14149846)

RBM-26 is expressed in the PLM and functions within neurons to protect against axon degeneration and prevent axon overlap defects. by Tamjid A. Chowdhury (14149846)

Mutations in <i>rbm-26</i> cause axon degeneration and axon overlap defects. by Tamjid A. Chowdhury (14149846)

Synthesis and Biological Evaluation of MEK/mTOR Multifunctional Inhibitors as Novel Anticancer Agents by Marcian E. Van Dort (21374093)

“…Additionally, compound LP-65 demonstrated significant modulation of MEK and mTOR signaling activity in human glioma cells (D54) and human melanoma cells (A375), with a corresponding decrease in cellular proliferation and migration. …”

Changes in growth characteristics (A = shoot fresh weight; B = shoot dry weight; C = root fresh weight; D = root dry weight) of M. stenopetala under drought conditions.... by Nadia Khater (22553166)

Subjects:

Expression of RBM-26 is disrupted by P80L and L13V missense mutations. by Tamjid A. Chowdhury (14149846)

The sagittal view of T2-weighted Magnetic Resonance Imaging represented mild decreased spinal cord diameter without any other lesions at second admission. by Hossein Pourmontaseri (19329565)

Contents of chlorophyll a, chlorophyll b (Chl a, Chl b) and carotenoid in <i>D</i>. <i>parva</i> cells under treatment of various concentrations of MeJA and GA3. by Lingru Ruan (18995544)

Subjects:

Tuning the Upper Critical Solution Temperature of the Polystyrene-Terpineol System toward a Low-Temperature Membrane Formation by Sulaiman Dhameri (22048528)

Subjects:

AZ10606120 treatment significantly increased cytotoxicity and reduced cell number in a dose-dependent manner. by Matthew Drill (22258391)

“…Cell numbers were significantly decreased in cells after treatment with AZ10606120 (50µM) compared to both temozolomide (TMZ; 50µM) treatment and untreated controls. …”

PBM significantly reduces hyperphosphorylation of tau with no effect on total tau expression. by Kevin J. Johnson (2647639)

Exploring Metalloproteome Remodeling in Calprotectin-Stressed Acinetobacter baumannii Using Chemoproteomics by Maximillian K. Osterberg (22514185)

Subjects: